Search research articles
Contact Us
Filters
Showing results (141-150 of 146) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 146 results.
Clinical Therapeutics
|
March 24, 2007
A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain
André D Beaulieu, Paul Peloso, William Bensen, et al.
Annals of the Rheumatic Diseases
|
June 7, 2013
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study
Bernard Combe, Bhaskar Dasgupta, Ingrid Louw, et al.
Annals of the Rheumatic Diseases
|
December 26, 2013
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
Iain B McInnes, Liz Thompson, Jon T Giles, et al.
Pain Research & Management
|
April 30, 2008
A randomized, double-blind, crossover comparison of the efficacy and safety of oral controlled-release tramadol and placebo in patients with painful osteoarthritis
C Thorne, A D Beaulieu, D J Callaghan, et al.
JAMA
|
January 24, 2023
Organization and Performance of US Health Systems
Nancy D Beaulieu, Michael E Chernew, J Michael McWilliams, et al.
Scandinavian Journal of Rheumatology
|
March 17, 2001
Tolerability profiles of rofecoxib (Vioxx) and Arthrotec. A comparison of six weeks treatment in patients with osteoarthritis
E Acevedo, O Castañeda, M Ugaz, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 146) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 146 results.
Clinical Therapeutics
|
March 24, 2007
A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain
André D Beaulieu, Paul Peloso, William Bensen, et al.
Annals of the Rheumatic Diseases
|
June 7, 2013
Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study
Bernard Combe, Bhaskar Dasgupta, Ingrid Louw, et al.
Annals of the Rheumatic Diseases
|
December 26, 2013
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
Iain B McInnes, Liz Thompson, Jon T Giles, et al.
Pain Research & Management
|
April 30, 2008
A randomized, double-blind, crossover comparison of the efficacy and safety of oral controlled-release tramadol and placebo in patients with painful osteoarthritis
C Thorne, A D Beaulieu, D J Callaghan, et al.
JAMA
|
January 24, 2023
Organization and Performance of US Health Systems
Nancy D Beaulieu, Michael E Chernew, J Michael McWilliams, et al.
Scandinavian Journal of Rheumatology
|
March 17, 2001
Tolerability profiles of rofecoxib (Vioxx) and Arthrotec. A comparison of six weeks treatment in patients with osteoarthritis
E Acevedo, O Castañeda, M Ugaz, et al.
Page
of 15